AWA
SGMO

Aaron Wealth Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Aaron Wealth Advisors’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,038
Closed -$523K – 724
2022
Q1 		$523K Buy
+3,038
New +$18.1K 0.01% 500

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Aaron Wealth Advisors's SGMO Position: Q2 2022 in Review

Aaron Wealth Advisors sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2022, closing a stake of 3,038 shares — an estimated $523K sold.

Aaron Wealth Advisors first reported a position in SGMO in Q1 2022 and held it in 1 quarter. The position peaked at $523K in Q1 2022. 188 funds tracked by Wall St. Rank hold SGMO as of Q2 2022.

  • Aaron Wealth Advisors reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2022 after selling out during the quarter.
  • Aaron Wealth Advisors sold 3,038 SANGAMO THERAPEUTICS INC shares in Q2 2022, an estimated $523K.
  • Aaron Wealth Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q1 2022 and held it in 1 quarter.
  • Aaron Wealth Advisors's SANGAMO THERAPEUTICS INC position peaked at $523K in Q1 2022.
  • 188 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2022.

Based on Aaron Wealth Advisors's 13F filing for Q2 2022, filed 22 Jul 2022.